Stockreport

Holoclara Announces $16 Million Series A Financing to Advance a Breakthrough Class of Worm-Derived Therapies for Allergic and Autoimmune Disease [Yahoo! Finance]

Hologic, Inc.  (HOLX) 
Last hologic, inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
PDF Capital to support clinical development of first-in-class, worm-derived medicines for allergies and autoimmune disorders and advancement of discovery engine Peter Bar [Read more]